- Home
- CLVT vs SLNO Comparison
CLVT vs SLNO Comparison
Compare CLVT & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLVT | SLNO |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CLVT | SLNO |
|---|---|---|
| Price | $3.36 | $44.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $4.50 | ★ $110.90 |
| AVG Volume (30 Days) | ★ 5.4M | 1.3M |
| Earning Date | 02-18-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,501,200,000.00 | $98,675,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $155.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.04 | $41.50 |
| 52 Week High | $5.74 | $90.32 |
Technical Indicators
Market Signals| Indicator | CLVT | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 45.02 | 36.12 |
| Support Level | $3.28 | $45.07 |
| Resistance Level | $3.41 | $47.98 |
| Average True Range (ATR) | 0.15 | 1.94 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 39.47 | 8.70 |
Price Performance
Historical ComparisonAbout CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.